GIPM
AUGX

G2 Investment Partners Management’s Augmedix, Inc. Common Stock AUGX Stock Holding History

G2 Investment Partners Management’s Portfolio AUGX Stock Details AUGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-820,000
Closed -$722K – 89
2024
Q2 		$722K Buy
820,000
+191,114
+30% +$394K 0.19% 70
2024
Q1 		$2.57M Buy
628,886
+28,886
+5% +$129K 0.68% 43
2023
Q4 		$3.51M Sell
600,000
-320,525
-35% -$1.69M 1.03% 36
2023
Q3 		$4.74M Buy
920,525
+350,635
+62% +$1.65M 1.16% 36
2023
Q2 		$2.74M Buy
+569,890
New +$1.97M 0.66% 46

Other funds holding AUGX

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
SM
Samjo Management New York $231M AUM 13.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.46% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.76% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

G2 Investment Partners Management's AUGX Position: Q3 2024 in Review

G2 Investment Partners Management sold out of Augmedix, Inc. Common Stock (AUGX) in Q3 2024, closing a stake of 820,000 shares — an estimated $722K sold.

G2 Investment Partners Management first reported a position in AUGX in Q2 2023 and held it in 5 quarters. The position peaked at $4.74M in Q3 2023. 45 funds tracked by Wall St. Rank hold AUGX as of Q3 2024.

  • G2 Investment Partners Management reported no remaining Augmedix, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • G2 Investment Partners Management sold 820,000 Augmedix, Inc. Common Stock shares in Q3 2024, an estimated $722K.
  • G2 Investment Partners Management first reported a position in Augmedix, Inc. Common Stock in Q2 2023 and held it in 5 quarters.
  • G2 Investment Partners Management's Augmedix, Inc. Common Stock position peaked at $4.74M in Q3 2023.
  • 45 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q3 2024.

Based on G2 Investment Partners Management's 13F filing for Q3 2024, filed 14 Nov 2024.